Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic dmards in norway in 2010-2019 – a country with a national tender system for prescription of costly drugs

HIGHLIGHTS

• who: Alen Brkic from the (UNIVERSITY) have published the research: Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs, in the Journal: (JOURNAL)
• what: In Norway, with a tax-based healthcare system, the authors show that treatment with b/tsDMARDs has become more available at a lower cost, and the threshold for starting b/tsDMARDs has decreased significantly.
• how: Data files from each center for each year were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.